Literature DB >> 19555692

Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4.

Lydia van der Steen1, Cornelis W Tuk, Jantine E Bakema, Gijs Kooij, Arie Reijerkerk, Gestur Vidarsson, Gerd Bouma, Georg Kraal, Helga E de Vries, Robert H J Beelen, Marjolein van Egmond.   

Abstract

BACKGROUND & AIMS: Exacerbations of ulcerative colitis (UC) are dominated by massive neutrophil influx in the lamina propria with concomitant mucosal ulceration. The prevalent antibody in this area is immunoglobulin A (IgA). Interestingly, the IgA Fc receptor (Fc(alpha)RI) potently activates neutrophils. As such, we investigated whether IgA-Fc(alpha)RI interaction contributes to tissue damage in UC.
METHODS: Response of neutrophils to bovine serum albumin-, IgG-, or IgA-coated beads and Escherichia coli was investigated with 3-dimensional culture systems, real-time video microscopy, and (fluorescence) microscopy. In vivo studies were performed using human Fc(alpha)RI transgenic mice or nontransgenic littermates. Microscopic slides of UC patients were stained for IgA, Fc(alpha)RI, and neutrophils.
RESULTS: In vitro and in vivo cross-linking of Fc(alpha)RI on neutrophils by serum IgA or uptake of IgA-coated E coli led to neutrophil migration. The responsible chemotactic factor was identified as leukotriene B4. Moreover, dimeric IgA (dIgA), which is produced in the lamina propria, but neither secretory IgA nor IgG, was equally capable of inducing neutrophil recruitment. We furthermore showed that Fc(alpha)RI(+)-neutrophils in the colon of UC patients had phagocytosed IgA-antigen complexes.
CONCLUSIONS: Neutrophils are the first cells that arrive at inflammatory sites once pathogens have crossed the epithelial barrier. Fc(alpha)RI-dIgA interactions therefore may constitute an essential activation step to recruit more neutrophils, hereby eradicating impending infections. However, excessive IgA-antigen complexes can sustain a perpetuating inflammatory loop in UC, hereby seriously aggravating morbidity. Novel therapeutic strategies that block dIgA-Fc(alpha)RI interactions, and therefore diminish neutrophil migration and activation, may dampen the uncontrolled inflammatory processes in these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19555692     DOI: 10.1053/j.gastro.2009.06.047

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

2.  Interaction of human, rat, and mouse immunoglobulin A (IgA) with Staphylococcal superantigen-like 7 (SSL7) decoy protein and leukocyte IgA receptor.

Authors:  Bruce D Wines; Paul A Ramsland; Halina M Trist; Sandra Gardam; Robert Brink; John D Fraser; P Mark Hogarth
Journal:  J Biol Chem       Date:  2011-07-22       Impact factor: 5.157

3.  Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.

Authors:  M Jack Borrok; Nadia M Luheshi; Nurten Beyaz; Gareth C Davies; James W Legg; Herren Wu; William F Dall'Acqua; Ping Tsui
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicity.

Authors:  Niels Heemskerk; Mandy Gruijs; A Robin Temming; Marieke H Heineke; Dennis Y Gout; Tessa Hellingman; Cornelis W Tuk; Paula J Winter; Suzanne Lissenberg-Thunnissen; Arthur Eh Bentlage; Marco de Donatis; Marijn Bögels; Thies Rösner; Thomas Valerius; Jantine E Bakema; Gestur Vidarsson; Marjolein van Egmond
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 5.  An Emerging Role for Neutrophil Extracellular Traps in IgA Vasculitis: A Mini-Review.

Authors:  Xiu-Qi Chen; Li Tu; Qing Tang; Li Huang; Yuan-Han Qin
Journal:  Front Immunol       Date:  2022-06-21       Impact factor: 8.786

Review 6.  Tissues: the unexplored frontier of antibody mediated immunity.

Authors:  Nicholas E Webb; Biana Bernshtein; Galit Alter
Journal:  Curr Opin Virol       Date:  2021-02-10       Impact factor: 7.090

7.  Carcinoma origin dictates differential skewing of monocyte function.

Authors:  Marijn Bögels; Rens Braster; Philip G Nijland; Nuray Gül; Wendy van de Luijtgaarden; Remond J A Fijneman; Gerrit A Meijer; Connie R Jimenez; Robert H J Beelen; Marjolein van Egmond
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

8.  Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.

Authors:  Marieke H Heineke; Lydia P E van der Steen; Rianne M Korthouwer; J Joris Hage; Johannes P M Langedijk; Joris J Benschop; Jantine E Bakema; Jerry W Slootstra; Marjolein van Egmond
Journal:  Eur J Immunol       Date:  2017-09-06       Impact factor: 5.532

9.  Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcus pneumoniae-Specific IgA and Th17 Mediated Protective Immunity.

Authors:  Ken Yoshii; Koji Hosomi; Atsushi Shimoyama; Yunru Wang; Haruki Yamaura; Takahiro Nagatake; Hidehiko Suzuki; Huangwenxian Lan; Hiroshi Kiyono; Koichi Fukase; Jun Kunisawa
Journal:  Microorganisms       Date:  2020-07-23

Review 10.  Immunoglobulin A and liver diseases.

Authors:  Tatsuo Inamine; Bernd Schnabl
Journal:  J Gastroenterol       Date:  2017-10-26       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.